The Pilot Study of the Efficacy of Polymyxin-B Hemoperfusion in Critically Ill Patients With Severe Sepsis
Condition: Severe SepsisInterventions: Procedure: Polymyxin-B Hemoperfusion; Procedure: Standard treatmentSponsor: Chulalongkorn UniversityRecruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 31, 2015 Category: Research Source Type: clinical trials
Effect of Systemic Oxygen on Corneal Epithelial Wound Healing in Diabetic Patients Undergoing Pars Plana Vitrectomy
Condition: Corneal DiseasesInterventions: Drug: Dexamethasone 0.1%, Neomycin Sulfate and Polymyxin B Sulfate topical eye drops four times daily; Drug: Homatropine 2% eye drops thrice daily; Drug: Oxygen gasSponsor: University of Science MalaysiaCompleted - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 8, 2015 Category: Research Source Type: clinical trials
Efficacy of Polymyxin B Against Infections Caused by Extensively Drug-resistant (XDR) Gram-Negative Bacteria
Condition: Hospital InfectionIntervention: Drug: Polymyxin BSponsor: Mahidol UniversityRecruiting - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 15, 2014 Category: Research Source Type: clinical trials
The Effects of a Polyethyleneimine-coated Membrane (oXiris™) for Hemofiltration Versus Polymyxin B- Immobilized Fibre Column (Toraymyxin™) for Hemoperfusion on Endotoxin Activity and Inflammatory Conditions in Septic Shock- A Randomized Controlled Pilot Study (ENDoX-study)
Condition: Patients in Septic ShockInterventions: Device: oXiris™ filter; Device: Toraymyxin Filter; Device: Standard of CareSponsor: University of ZurichRecruiting - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 30, 2013 Category: Research Source Type: clinical trials
Safety and Efficacy of Polymyxin B Hemoperfusion (PMX) for Septic Shock
Conditions: Septic Shock; EndotoxemiaIntervention: Device: TORAYMYXIN PMX-20R (PMX cartridge)Sponsor: Spectral Diagnostics (US) Inc.Recruiting - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 8, 2010 Category: Research Source Type: clinical trials
Clearance of Nasal Staphylococcus Aureus With Triple Antibiotic Ointment
Condition: Nasal Carriers of Staphylococcus AureusIntervention: Drug: Neosporin (polymyxin B 5,000units, bacitracin 400 units, neomycin 3.5mg)Sponsor: Northwestern UniversityCompleted - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 15, 2009 Category: Research Source Type: clinical trials
